Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. (BIO) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
bio · stock forecast · 14 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 14 Wall Street analysts in the past 3 months
Buy
14 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$335
Consensus
$322
+9.3% upside
Low
$310
Median: $320 · Last Close: $294.22
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$321.67
9.3% upside
High Target
$335
13.9%
Low Target
$310
5.4%
Current Price
$294.22
as of today
Based on analyst price targets, the BIO stock price prediction for the next 12 months ranges from $310 to $335. The consensus BIO price forecast of $321.67 implies 9.3% upside from the current price of $294.22.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $306.01 | ↑ 4.01% |
1-day model range: $304.02–$308. Peak: $308 (+4.01%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $250 | -15.1% |
| 2028 | $227 | -22.8% |
| 2029 | $215 | -27.1% |
| 2030 | $208 | -29.4% |
| 2031 | — | -30.8% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · BIO · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-01 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2026-04-07 | Citigroup | Downgrade ↓ | Buy→Neutral |
| 2026-02-16 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-10-30 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-10-30 | Citigroup | Maintains | Buy→Buy |
| 2025-08-01 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-08-01 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-06-09 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2025-05-02 | RBC Capital | Maintains | Outperform→Outperform |
| 2025-05-02 | UBS | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Bio-Rad Laboratories, Inc. (BIO) stock. Of the recent 74 rating actions, 5 were upgrades and 4 were downgrades. 14 analysts currently cover BIO.
Analyst Recommendation Trends
BIO analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$2.6B
↓ 6.6% YoY
Revenue Next Year
$2.7B
↑ 3.3% YoY
EPS This Year
$9.04
EPS Next Year
$9.96
↑ 10.2% YoY
EPS ForecastReported vs Estimated
Analysts forecast BIO EPS of $9.04 for the current fiscal year, based on estimates from 2 analysts. The BIO revenue forecast is $2.6B for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The BIO stock forecast is supported by two independent data sources: analyst consensus ratings from 14 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus BIO price target is $321.67 (+9.3% upside), with an analyst consensus of Buy.
The BIO short-term stock prediction for tomorrow is $306.01 (+4.01%). The BIO stock price prediction for 2027 estimates an average of $250. The BIO stock prediction for 2030 projects a range of $193–$222.
Bio-Rad Laboratories, Inc. trades on NYSE under the ticker BIO. The BIO stock outlook for 2027 is broadly positive, supported by a Buy consensus among 57% of covering analysts.
Frequently asked questions
BIO forecast · 8 questionsAccording to 14 Wall Street analysts, the average 12-month BIO price target is $321.67, with a high forecast of $335.00 and a low of $310.00. The median price target is shown in the chart above when available. This implies +9.3% potential upside from the current price of $294.22.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.